Tizanidine Tablet
Product Images NDC 50090-5767

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-5767). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)

Chemical structure of Tizanidine hydrochloride, showing a chlorinated benzene ring fused with an azole ring and an attached imidazoline group.*

FDA Label Image

Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)

A pharmacokinetic chart showing plasma Tizanidine concentration (ng/mL) over 26 hours from dosing for 4 mg tablets and capsules, both with and without food. The graph compares concentration-time profiles for four groups: tablets with food, tablets without food, capsules with food, and capsules without food.*

FDA Label Image

Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)

A line graph showing improvement in Ashworth Score over 6 hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The Y-axis represents improvement in Ashworth Score, and the X-axis represents hours post-dose. Data points include error bars indicating variability.*

FDA Label Image

Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)

A line graph comparing improvement in Ashworth Score over time between tizanidine (mean dose 28.8 mg) and placebo groups. The x-axis shows time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carry Forward). The y-axis measures improvement in Ashworth Score, with negative values indicating greater improvement. Tizanidine data points show larger improvements compared to placebo, with error bars indicating variability at each time point.*

FDA Label Image

Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)

FDA Label Image

Label Image (Lbl500905767)

Tizanidine 4 mg oral tablets label from A-S Medication Solutions. The label indicates each tablet contains 4.575 mg tizanidine hydrochloride, USP, equivalent to 4 mg base. The package contains 120 tablets with storage instructions of 65 to 77 degrees Fahrenheit. Manufactured in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.